How does colchicine impact inflammation in the coronary arteries?

About this episode

This episode discusses the impact of colchicine on inflammation in coronary arteries based on the LoDoCo2 trial.

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Aernoud Fiolet from Utrecht in the Netherlands. They discuss the imaging substudy of the LoDoCo2 trial, which tested colchicine in patients with chronic coronary syndromes. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper:https://heart.bmj.com/content/111/23/1156.long

People in this episode

Host: Professor James Rudd

Guest: Dr Aernoud Fiolet

Topics covered

• colchicine
• inflammation
• coronary arteries
• chronic coronary syndromes
• LoDoCo2 trial
• medical imaging

Keywords

• colchicine
• inflammation
• coronary arteries
• chronic coronary syndromes
• LoDoCo2 trial
• medical imaging
• heart health

Mentioned in this episode

Organizations: LoDoCo2 trial, BMJ Group

Places: Utrecht

More episodes of Heart Podcast

• Heart failure with preserved ejection fraction plus AF - challenges and opportunities · June 2, 2026 · 31 min
• Can routine cardiac CT in patients with acute coronary syndrome and prior bypass grafts improve clinical decisions? · May 19, 2026 · 15 min
• Do older patients benefit from heart failure therapies? · May 5, 2026 · 16 min
• Simulation training in Cardiology - a missed opportunity? · April 21, 2026 · 18 min
• The natural history of aortic regurgitation · April 7, 2026 · 21 min
• Current and emerging treatments for cardiac amyloidosis · March 24, 2026 · 21 min